MedPath

Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older

Completed
Conditions
Vitreomacular Adhesion
Registration Number
NCT02160340
Lead Sponsor
Nova Southeastern University
Brief Summary

The purpose of this study is to evaluate the prevalence of vitreomacular adhesion (VMA) in patients 40 years and older using Spectral Domain Optical Coherence Tomography.

Detailed Description

As a function of age, liquefaction of the vitreous body results in separation of the vitreous cavity from the retina. This posterior vitreous separation may be incomplete, leading to areas of residual VMA. These adhesions can result in maculopathies such as vitreomacular traction syndrome, macular hole, epiretinal membrane, cystoid macular edema, diabetic macular edema, neovascularization in diabetic retinopathy and retinal vein occlusion, exudative age-related macular degeneration, and myopic traction maculopathy. VMA may lead to pathological sequelae due to the static and dynamic anteroposterior tractional forces to the surface of the macula. The resultant complication will depend on the size and strength of the traction, with smaller areas of adhesion leading to greater traction. Identifying the prevalence of vitreomacular adhesion and its associated complications will yield valuable, new epidemiologic data, leading to improved diagnosis and management of patients with this condition. The prevalence of vitreomacular adhesion in specific age groups has not been investigated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1584
Inclusion Criteria

40 years and older

  • Clear media
Exclusion Criteria

Less than 40 years of age

  • Prior history of vitreoretinal surgery or pharmacotherapy with intravitreal injection
  • Dense media opacity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
What is the overall prevalence of Vitreomacular adhesion in the population 40 years and older?Two years

Prevalence will be measured using Spectral Domain Optical Coherence Tomography. Tomography scans will be evaluated for the presence or absence of vitreomacular adhesion.

Secondary Outcome Measures
NameTimeMethod
Is there is a significant correlation between VMA and various maculopathies including diabetic macular edema, retinal vascular occlusion, and age-related macular degeneration?2 years

Spectral domain optical coherence tomography scans will be used to evaluate for the presence of isolated or concomitant vitreomacular adhesion.

Trial Locations

Locations (18)

Schaeffer Eye Center

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Leo Semes

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Schwartz Laser Eye Center

πŸ‡ΊπŸ‡Έ

Scottsdale, Arizona, United States

VA Greater Los Angeles Healthcare System

πŸ‡ΊπŸ‡Έ

Sepulveda, California, United States

Front Range Eye Associates

πŸ‡ΊπŸ‡Έ

Broomfield, Colorado, United States

Aran Eye Associates

πŸ‡ΊπŸ‡Έ

Coral Gables, Florida, United States

Nova Southeastern University

πŸ‡ΊπŸ‡Έ

Fort Lauderdale, Florida, United States

Retina Macula Specialists of Miami

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Murray Ocular Oncology and Retina

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Vitreous and Retina Consultants

πŸ‡ΊπŸ‡Έ

Winter Haven, Florida, United States

Scroll for more (8 remaining)
Schaeffer Eye Center
πŸ‡ΊπŸ‡ΈBirmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.